SCHEMBL6536889

SCHEMBL6536889

Clc1ccc(-n2[c]ccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BIRC5 O15392 1/20 0.41
NOTUM Q6P988 4/20 0.39
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 1/20 0.35
CYP2A6 P11509 1/20 0.35
MGLL Q99685 1/20 0.34
POLB P06746 2/20 0.33
APOBEC3G Q9HC16 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP19A1 P11511 1/20 0.33
ALDH1A1 P00352 1/20 0.32
ALOX15 P16050 1/20 0.32
HTT P42858 1/20 0.32
ATM Q13315 1/20 0.32
HTR3E A5X5Y0 1/20 0.32
HTR3B O95264 1/20 0.32
ADRB1 P08588 1/20 0.32
HTR3A P46098 1/20 0.32
HTR3D Q70Z44 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11574910 0.78 MGLL (0.44) NOTUMMEN1KMT2ALMNAMGLL
SCHEMBL3633550 0.72 TSHR (0.38) NOTUMMEN1KMT2ALMNAHTT
SCHEMBL535999 0.68 MGLL (0.39) NOTUMMEN1KMT2ALMNAMGLL
SCHEMBL6441670 0.67
SCHEMBL300545 0.65 KEAP1 (0.43) NOTUMMEN1KMT2AMGLLPOLB
SCHEMBL196307 0.64 NOTUM (0.52) BIRC5NOTUMMEN1KMT2ALMNA
SCHEMBL2092435 0.64 NOTUM (0.42) BIRC5NOTUMMEN1KMT2ALMNA
SCHEMBL28814626 0.64 NOTUM (0.42) NOTUMLMNACYP2A6MGLLPOLB
SCHEMBL3627258 0.63 SMN1; SMN2 (0.33) MEN1KMT2ALMNAALDH1A1ALOX15
SCHEMBL344002 0.61 NOTUM (0.48) NOTUMLMNACYP2A6MGLLPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1425015-A4 TETRAHYDROQUINOLINE DERIVATIVES AS ANTITHROMBOTIC AGENTS BRISTOL MYERS SQUIBB CO (US) 2004-12-15 EP disclosed
US-6825208-B2 SELECTIVE INHIBITORS OF SERINE PROTEASE ENZYMES, ESPECIALLY FACTOR VIIA; MODULATION OF THE COAGULATION CASCADE. BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-11-30 US disclosed
EP-1425015-A2 TETRAHYDROQUINOLINE DERIVATIVES AS ANTITHROMBOTIC AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-06-09 EP disclosed
WO-2003015715-A2 TETRAHYDROQUINOLINE DERIVATIVES AS ANTITHROMBOTIC AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-02-27 WO disclosed